Clinical Trial Update: A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of HRS9531 injection in adults with obstructive sleep apnea and obesity. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Bstructive Sleep Apnea (OSA) and Obesity | Phase 3 | Status: RECRUITING